PRINCIPAL DISPLAY PANEL - 500 mg Vial Label
Single-dose Vial
Rx only
Deferoxamine
Mesylate
for Injection, USP
500 mg/vial
INTRAVENOUS,
INTRAMUSCULAR, SUBCUTANEOUS USE
Distributed by
Hospira, Inc., Lake Forest, IL 60045 USA

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton
4 Single-dose Vials
Rx only
NDC 0409-2336-10
Contains 4 of NDC 0409-2336-01
Deferoxamine Mesylate
for Injection, USP
500 mg/vial
Hospira
Each vial contains deferoxamine mesylate USP, 500 mg in
lyophilized form.
INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS USE
Discard unused portion.

PRINCIPAL DISPLAY PANEL - 2 g Vial Label
Fliptop Vial
Rx only
Deferoxamine
Mesylate
for Injection, USP
2 g/vial
For single-dose only.
For S.C., I.M. or I.V. Use

PRINCIPAL DISPLAY PANEL - 2 g Vial Carton
4 Fliptop Vials
Rx only
NDC 0409-2337-25
Contains 4 of NDC 0409-2337-15
Deferoxamine Mesylate
for Injection, USP
2 g/vial
Hospira
Each vial contains deferoxamine mesylate USP, 2 g in lyophilized form.
For subcutaneous, intramuscular or intravenous administration.
For single-dose only. Discard unused portion.
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
